Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping

NCT06385236 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT06385236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06385236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
Lead sponsor
University of California, San Diego
Phase
Phase 4
Overall status
Recruiting
Start date
February 19, 2024
Completion date
January 31, 2028
Enrollment
120 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe asthma